You are using an older browser version. Please use a supported version for the best MSN experience.

Wockhardt gets US FDA nod for generic anti-bacterial drug

LiveMint logoLiveMint 21-03-2017 PTI

New Delhi: Drug firm Wockhardt has received approval from the US health regulator to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market.

The application for the product to the US Food and Drug Administration (USFDA) was made by the company’s subsidiary Wockhardt Bio AG, the Mumbai-based company said in a regulatory filing.

“Wockhardt Bio AG had filed this abbreviated new drug application (ANDA) in collaboration with Fresinius Kabi, Italy (FKAI) where the product development was completed,” it added.

The ANDA will be manufactured commercially at FKAI, Mitim, Italy, it said. Wockhardt stock closed 2.54% down at Rs727.60 on BSE.

More From LiveMint

image beaconimage beaconimage beacon